Product Images Beizray
View Photos of Packaging, Labels & Appearance
- Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 01
- Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 02
- Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 03
- Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 04
- Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 05
- Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 06
- Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 07
- Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 08
- Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 09
- Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 10
- Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 11
- vial - 8af4a374 dc96 4931 943e c7b5e3ad1044 12
- 80 mg kit - 8af4a374 dc96 4931 943e c7b5e3ad1044 13
- 160 mg kit - 8af4a374 dc96 4931 943e c7b5e3ad1044 14
- 80 mg carton - 8af4a374 dc96 4931 943e c7b5e3ad1044 15
Product Label Images
The following 15 images provide visual information about the product associated with Beizray NDC 70710-2091 by Zydus Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 01
Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 02
Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 03
Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 04
This text appears to show a graph or chart related to cumulative probability, overall survival, and survival time in months. The logrank p-value is noted as 0.010. The graph seems to display data points corresponding to different months and their respective probabilities.*
Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 05
This is a description of a chart showing cumulative probability of overall survival over different time intervals in months. The logrank p-value is shown as 0.013, indicating statistical significance. The chart also includes numeric values ranging from 00 to 10.*
Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 06
Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 07
Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 08
Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 09
Progression Free Survival Probability (%): 2% Progression Free Survival Time (months)*
Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 10
Image - 8af4a374 dc96 4931 943e c7b5e3ad1044 11
vial - 8af4a374 dc96 4931 943e c7b5e3ad1044 12
80 mg kit - 8af4a374 dc96 4931 943e c7b5e3ad1044 13
BEIZRAY™ is a docetaxel injection used for intravenous infusion only. Each vial contains 80 mg/4 mL of the medication and must be diluted in a solution containing Albumin Human USP and 0.8% Sodium Chloride Injection. It is important not to substitute BEIZRAY with other docetaxel products. The drug is labeled as a hazardous substance and comes with specific instructions for handling and disposal. The product details are available in a standardized format including LOT number, expiration date, and additional identification codes for safety and traceability purposes.*
160 mg kit - 8af4a374 dc96 4931 943e c7b5e3ad1044 14
This is a description for BEIZRAY™ (docetaxel) injection in vials of 80 mg/4 mL for intravenous infusion only. The product contains a solution with human albumin USP. The label warns that BEIZRAY should not be substituted with other products, and emphasizes that it is hazardous. The dimensions of the vial are approximately 53mm x 105mm. The label includes a lot number and other applicable information related to the product.*
80 mg carton - 8af4a374 dc96 4931 943e c7b5e3ad1044 15
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
